US Pauses J&J COVID-19 Vaccine Over Rare Blood Clots
1 sourceUpdated Apr 13, 2021
U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six women under 50 who had received it developed rare blood clots, dealing a fresh setback to efforts to…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup